Location of Repository

Hdm2 recruits a hypoxia-sensitive corepressor to negatively regulate p53-dependent transcription

By Alexander H. Mirnezami, Sandra J. Campbell, Matthew Darley, John N. Primrose, Peter W.M. Johnson and Jeremy P. Blaydes

Abstract

The transcription factor p53 lies at the center of a protein network that controls cell cycle progression and commitment to apoptosis. p53 is inactive in proliferating cells, largely because of negative regulation by the Hdm2/Mdm2 oncoprotein, with which it physically associates. Release from this negative regulation is sufficient to activate p53 and can be triggered in cells by multiple stimuli through diverse pathways. This diversity is achieved in part because Hdm2 uses multiple mechanisms to inactivate p53; it targets p53 for ubiquitination and degradation by the proteosome, shuttles it out of the nucleus and into the cytoplasm, prevents its interaction with transcriptional coactivators, and contains an intrinsic transcriptional repressor activity. Here we show that Hdm2 can also repress p53 activity through the recruitment of a known transcriptional corepressor, hCtBP2. This interaction, and consequent repression of p53-dependent transcription, is relieved under hypoxia or hypoxia-mimicking conditions that are known to increase levels of intracellular NADH. CtBP proteins can undergo an NADH-induced conformational change, which we show here results in a loss of their Hdm2 binding ability. This pathway represents a novel mechanism whereby p53 activity can be induced by cellular stress.<br/

Topics: QH426
Year: 2003
OAI identifier: oai:eprints.soton.ac.uk:26486
Provided by: e-Prints Soton

Suggested articles

Preview

Citations

  1. (1999). 10 Hdm2 recruits hCtBP2 to p53 Mirnezami et al 27. Meloni AR, Smith EJ, Nevins JR: A mechanism for Rb/p130-mediated transcription repression involving recruitment of the CtBP corepressor.
  2. (1999). a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation. Embo J
  3. (2001). Acetylation of nuclear hormone receptor-interacting protein RIP140 regulates binding of the transcriptional corepressor CtBP. Mol Cell Biol
  4. (1997). AG: Isolation and identification of the human homolog of a new p53-binding protein, Mdmx. Genomics
  5. (1998). AJ: Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol Cell Biol
  6. (1998). AJ: Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein.
  7. (2000). AJ: Surfing the p53 network. Nature
  8. (2001). AM: The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nat Cell Biol
  9. (2002). Appella E, Yao TP: MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. Embo J
  10. (1998). C: Signaling to p53: breaking the MDM2-p53 circuit. Cell
  11. (2003). Chinnadurai G: Association of class I histone deacetylases with transcriptional corepressor CtBP. FEBS Lett
  12. (2002). CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol Cell
  13. (2000). DP: An Nterminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene
  14. (2001). Giaccia A: Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol Cell Biol
  15. (1996). Giaccia AJ: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours.
  16. (2002). H: MDM2 Inhibits PCAF-mediated p53 acetylation.
  17. (2001). H: The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling. Blood
  18. (1999). Identification of CtBP1 and CtBP2 as corepressors of zinc finger- homeodomain factor deltaEF1. Mol Cell Biol
  19. (2000). Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity.
  20. (1997). Mdm2 promotes the rapid degradation of p53. Nature
  21. (2001). MDM2: life without p53. Trends Genet
  22. (1999). Murine double minute (MDM2) blocks p53-coactivator interaction, a new mechanism for inhibition of p53-dependent gene expression.
  23. (1997). Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett
  24. (2002). Overlapping and unique roles for C-terminal binding protein 1
  25. (2002). RH: Regulation of corepressor function by nuclear NADH.
  26. (2003). SM: Cterminal-binding protein corepresses epithelial and proapoptotic gene expression programs.
  27. (1998). Svensson C: The carboxy-terminal region of adenovirus E1A activates transcription through targeting of a C-terminal binding proteinhistone deacetylase complex. FEBS Lett
  28. (2001). The CtBP family: enigmatic and enzymatic transcriptional corepressors. Bioessays
  29. (1997). Tjian R: Repression of p53-mediated transcription by MDM2: a dual mechanism. Genes Dev
  30. (1997). Vousden KH: Regulation of p53 stability by Mdm2. Nature
  31. (2000). Vousden KH: Stress signals utilize multiple pathways To stabilize p53. Mol Cell Biol
  32. (2001). Wasylyk B: The contribution of the acidic domain of MDM2 to p53 and MDM2 stability. Oncogene
  33. (1999). WH: Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.